APO Research
Talk to an analyst

APO RESEARCH · REPORT

Extracorporeal Shock Wave Lithotripsy (ESWL)

Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones (urinary calculus) and biliary calculi (stones in the gallbladder or in the liver) using an acoustic pulse. It is also reported to be used for salivary stones and pancreatic stones. It is mainly used in hospital.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones (urinary calculus) and biliary calculi (stones in the gallbladder or in the liver) using an acoustic pulse. It is also reported to be used for salivary stones and pancreatic stones. It is mainly used in hospital.

Selected research

Market Outlook & Growth Opportunities

Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Outlook and Growth Opportunities 2026

2 January 2026203 pages

Choose your research edition.

Industry ResearchExtracorporeal Shock Wave Lithotripsy (ESWL) Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Extracorporeal Shock Wave Lithotripsy (ESWL) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Extracorporeal Shock Wave Lithotripsy (ESWL) Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Extracorporeal Shock Wave Lithotripsy (ESWL) Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones (urinary calculus) and biliary calculi (stones in the gallbladder or in the liver) using an acoustic pulse. It is also reported to be used for salivary stones and pancreatic stones. It is mainly used in hospital.

The major players in global Extracorporeal Shock Wave Lithotripsy (ESWL) market include WIKKON, Hyde, Sody, etc. The top 3 players occupy about 30% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 75% of the global market. B-ultrasound ESWL is the main type, with a share about 70%. Kidney Stone is the main application, which holds a share about 65%.

This report provides an overview of the global Extracorporeal Shock Wave Lithotripsy (ESWL) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Extracorporeal Shock Wave Lithotripsy (ESWL) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Extracorporeal Shock Wave Lithotripsy (ESWL) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Extracorporeal Shock Wave Lithotripsy (ESWL) market.

Extracorporeal Shock Wave Lithotripsy (ESWL) Segment by Company

WIKKON

HYDE

Sody

Haibin

Comermy

Dornier

Richard-Wolf

MTS

DirexGroup

Siemens

EDAP TMS

Storz Medical

Medispec

ELMED

EMD

US

Allengers

Extracorporeal Shock Wave Lithotripsy (ESWL) Segment by Type

B-ultrasound ESWL

X-ray ESWL

X-ray & B-ultrasound ESWL

Extracorporeal Shock Wave Lithotripsy (ESWL) Segment by Application

Kidney Stone

Biliary Calculi

Salivary Stones

Pancreatic Stones

Others

Extracorporeal Shock Wave Lithotripsy (ESWL) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Extracorporeal Shock Wave Lithotripsy (ESWL) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Extracorporeal Shock Wave Lithotripsy (ESWL) key companies, revenue, market share, and recent developments.

3. To split the Extracorporeal Shock Wave Lithotripsy (ESWL) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Extracorporeal Shock Wave Lithotripsy (ESWL) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Extracorporeal Shock Wave Lithotripsy (ESWL) significant trends, drivers, influence factors in global and regions.

6. To analyze Extracorporeal Shock Wave Lithotripsy (ESWL) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Extracorporeal Shock Wave Lithotripsy (ESWL) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Extracorporeal Shock Wave Lithotripsy (ESWL) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Extracorporeal Shock Wave Lithotripsy (ESWL).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Extracorporeal Shock Wave Lithotripsy (ESWL) industry.

Chapter 3: Detailed analysis of Extracorporeal Shock Wave Lithotripsy (ESWL) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Extracorporeal Shock Wave Lithotripsy (ESWL) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Extracorporeal Shock Wave Lithotripsy (ESWL) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Trends Table 2. Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Drivers Table 3. Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Opportunities and Challenges Table 4. Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Restraints Table 5. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Company (2021-2026) Table 7. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Key Company Manufacturing Base & Headquarters Table 9. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Company, Product Type & Application Table 10. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Extracorporeal Shock Wave Lithotripsy (ESWL) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of B-ultrasound ESWL Table 15. Significant Companies of X-ray ESWL Table 16. Significant Companies of X-ray & B-ultrasound ESWL Table 17. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type (2021-2026) Table 21. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Kidney Stone Table 23. Significant Companies of Biliary Calculi Table 24. Significant Companies of Salivary Stones Table 25. Significant Companies of Pancreatic Stones Table 26. Significant Companies of Others Table 27. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application (2021-2026) Table 31. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application (2027-2032) Table 32. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Region (2021-2026) Table 35. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Region (2027-2032) Table 37. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Market Share by Country (2021-2026) Table 40. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Market Share by Country (2027-2032) Table 42. WIKKON Company Information Table 43. WIKKON Business Overview Table 44. WIKKON Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. WIKKON Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 46. WIKKON Recent Development Table 47. HYDE Company Information Table 48. HYDE Business Overview Table 49. HYDE Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. HYDE Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 51. HYDE Recent Development Table 52. Sody Company Information Table 53. Sody Business Overview Table 54. Sody Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Sody Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 56. Sody Recent Development Table 57. Haibin Company Information Table 58. Haibin Business Overview Table 59. Haibin Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Haibin Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 61. Haibin Recent Development Table 62. Comermy Company Information Table 63. Comermy Business Overview Table 64. Comermy Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Comermy Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 66. Comermy Recent Development Table 67. Dornier Company Information Table 68. Dornier Business Overview Table 69. Dornier Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Dornier Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 71. Dornier Recent Development Table 72. Richard-Wolf Company Information Table 73. Richard-Wolf Business Overview Table 74. Richard-Wolf Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Richard-Wolf Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 76. Richard-Wolf Recent Development Table 77. MTS Company Information Table 78. MTS Business Overview Table 79. MTS Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. MTS Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 81. MTS Recent Development Table 82. DirexGroup Company Information Table 83. DirexGroup Business Overview Table 84. DirexGroup Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. DirexGroup Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 86. DirexGroup Recent Development Table 87. Siemens Company Information Table 88. Siemens Business Overview Table 89. Siemens Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Siemens Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 91. Siemens Recent Development Table 92. EDAP TMS Company Information Table 93. EDAP TMS Business Overview Table 94. EDAP TMS Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. EDAP TMS Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 96. EDAP TMS Recent Development Table 97. Storz Medical Company Information Table 98. Storz Medical Business Overview Table 99. Storz Medical Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Storz Medical Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 101. Storz Medical Recent Development Table 102. Medispec Company Information Table 103. Medispec Business Overview Table 104. Medispec Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Medispec Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 106. Medispec Recent Development Table 107. ELMED Company Information Table 108. ELMED Business Overview Table 109. ELMED Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. ELMED Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 111. ELMED Recent Development Table 112. EMD Company Information Table 113. EMD Business Overview Table 114. EMD Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. EMD Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 116. EMD Recent Development Table 117. US Company Information Table 118. US Business Overview Table 119. US Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. US Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 121. US Recent Development Table 122. Allengers Company Information Table 123. Allengers Business Overview Table 124. Allengers Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Allengers Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 126. Allengers Recent Development Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Extracorporeal Shock Wave Lithotripsy (ESWL) Product Image Figure 2. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size (2021-2032) & (US$ Million) Figure 4. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. B-ultrasound ESWL Image Figure 8. X-ray ESWL Image Figure 9. X-ray & B-ultrasound ESWL Image Figure 10. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type (2021-2032) Figure 13. Kidney Stone Image Figure 14. Biliary Calculi Image Figure 15. Salivary Stones Image Figure 16. Pancreatic Stones Image Figure 17. Others Image Figure 18. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application (2021-2032) Figure 21. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value (2021-2032) & (US$ Million) Figure 24. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value (2021-2032) & (US$ Million) Figure 30. South America Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • B-ultrasound ESWL
  • X-ray ESWL
  • X-ray & B-ultrasound ESWL
Applications
  • Kidney Stone
  • Biliary Calculi
  • Salivary Stones
  • Pancreatic Stones
  • Others
Companies covered
  • WIKKON
  • HYDE
  • Sody
  • Haibin
  • Comermy
  • Dornier
  • Richard-Wolf
  • MTS
  • DirexGroup
  • Siemens
  • EDAP TMS
  • Storz Medical
  • Medispec
  • ELMED
  • EMD
  • US
  • Allengers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Extracorporeal Shock Wave Lithotripsy (ESWL) Market Dynamics
  1. 2.1 Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Trends
  2. 2.2 Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Drivers
  3. 2.3 Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Opportunities and Challenges
  4. 2.4 Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Restraints
3 Extracorporeal Shock Wave Lithotripsy (ESWL) Market by Company
  1. 3.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Company Revenue Ranking in 2025
  2. 3.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Company (2021-2026)
  3. 3.3 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Company Ranking (2024-2026)
  4. 3.4 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Company Manufacturing Base and Headquarters
  5. 3.5 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Company Product Type and Application
  6. 3.6 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Extracorporeal Shock Wave Lithotripsy (ESWL) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Extracorporeal Shock Wave Lithotripsy (ESWL) Market by Type
  1. 4.1 Extracorporeal Shock Wave Lithotripsy (ESWL) Type Introduction
  2. 4.1.1 B-ultrasound ESWL
  3. 4.1.2 X-ray ESWL
  4. 4.1.3 X-ray & B-ultrasound ESWL
  5. 4.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Type
  6. 4.2.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Type (2021-2032)
  8. 4.2.3 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type (2021-2032)
5 Extracorporeal Shock Wave Lithotripsy (ESWL) Market by Application
  1. 5.1 Extracorporeal Shock Wave Lithotripsy (ESWL) Application Introduction
  2. 5.1.1 Kidney Stone
  3. 5.1.2 Biliary Calculi
  4. 5.1.3 Salivary Stones
  5. 5.1.4 Pancreatic Stones
  6. 5.1.5 Others
  7. 5.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Application
  8. 5.2.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Application (2021-2032)
  10. 5.2.3 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application (2021-2032)
6 Extracorporeal Shock Wave Lithotripsy (ESWL) Regional Value Analysis
  1. 6.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value (2021-2032)
  7. 6.3.2 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value (2021-2032)
  10. 6.4.2 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value (2021-2032)
  16. 6.6.2 South America Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Country, 2025 VS 2032
7 Extracorporeal Shock Wave Lithotripsy (ESWL) Country-level Value Analysis
  1. 7.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Extracorporeal Shock Wave Lithotripsy (ESWL) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 WIKKON
  2. 8.1.1 WIKKON Company Information
  3. 8.1.2 WIKKON Business Overview
  4. 8.1.3 WIKKON Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 WIKKON Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  6. 8.1.5 WIKKON Recent Developments
  7. 8.2 HYDE
  8. 8.2.1 HYDE Company Information
  9. 8.2.2 HYDE Business Overview
  10. 8.2.3 HYDE Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 HYDE Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  12. 8.2.5 HYDE Recent Developments
  13. 8.3 Sody
  14. 8.3.1 Sody Company Information
  15. 8.3.2 Sody Business Overview
  16. 8.3.3 Sody Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sody Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  18. 8.3.5 Sody Recent Developments
  19. 8.4 Haibin
  20. 8.4.1 Haibin Company Information
  21. 8.4.2 Haibin Business Overview
  22. 8.4.3 Haibin Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Haibin Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  24. 8.4.5 Haibin Recent Developments
  25. 8.5 Comermy
  26. 8.5.1 Comermy Company Information
  27. 8.5.2 Comermy Business Overview
  28. 8.5.3 Comermy Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Comermy Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  30. 8.5.5 Comermy Recent Developments
  31. 8.6 Dornier
  32. 8.6.1 Dornier Company Information
  33. 8.6.2 Dornier Business Overview
  34. 8.6.3 Dornier Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Dornier Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  36. 8.6.5 Dornier Recent Developments
  37. 8.7 Richard-Wolf
  38. 8.7.1 Richard-Wolf Company Information
  39. 8.7.2 Richard-Wolf Business Overview
  40. 8.7.3 Richard-Wolf Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Richard-Wolf Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  42. 8.7.5 Richard-Wolf Recent Developments
  43. 8.8 MTS
  44. 8.8.1 MTS Company Information
  45. 8.8.2 MTS Business Overview
  46. 8.8.3 MTS Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MTS Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  48. 8.8.5 MTS Recent Developments
  49. 8.9 DirexGroup
  50. 8.9.1 DirexGroup Company Information
  51. 8.9.2 DirexGroup Business Overview
  52. 8.9.3 DirexGroup Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 DirexGroup Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  54. 8.9.5 DirexGroup Recent Developments
  55. 8.10 Siemens
  56. 8.10.1 Siemens Company Information
  57. 8.10.2 Siemens Business Overview
  58. 8.10.3 Siemens Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Siemens Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  60. 8.10.5 Siemens Recent Developments
  61. 8.11 EDAP TMS
  62. 8.11.1 EDAP TMS Company Information
  63. 8.11.2 EDAP TMS Business Overview
  64. 8.11.3 EDAP TMS Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  65. 8.11.4 EDAP TMS Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  66. 8.11.5 EDAP TMS Recent Developments
  67. 8.12 Storz Medical
  68. 8.12.1 Storz Medical Company Information
  69. 8.12.2 Storz Medical Business Overview
  70. 8.12.3 Storz Medical Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Storz Medical Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  72. 8.12.5 Storz Medical Recent Developments
  73. 8.13 Medispec
  74. 8.13.1 Medispec Company Information
  75. 8.13.2 Medispec Business Overview
  76. 8.13.3 Medispec Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Medispec Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  78. 8.13.5 Medispec Recent Developments
  79. 8.14 ELMED
  80. 8.14.1 ELMED Company Information
  81. 8.14.2 ELMED Business Overview
  82. 8.14.3 ELMED Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ELMED Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  84. 8.14.5 ELMED Recent Developments
  85. 8.15 EMD
  86. 8.15.1 EMD Company Information
  87. 8.15.2 EMD Business Overview
  88. 8.15.3 EMD Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  89. 8.15.4 EMD Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  90. 8.15.5 EMD Recent Developments
  91. 8.16 US
  92. 8.16.1 US Company Information
  93. 8.16.2 US Business Overview
  94. 8.16.3 US Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  95. 8.16.4 US Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  96. 8.16.5 US Recent Developments
  97. 8.17 Allengers
  98. 8.17.1 Allengers Company Information
  99. 8.17.2 Allengers Business Overview
  100. 8.17.3 Allengers Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Allengers Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  102. 8.17.5 Allengers Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst